The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion

Gokcen Gokce,1 Gungor Sobaci,2 Ali Hakan Durukan,2 Fazil Cuneyt Erdurman31Department of Ophthalmology, Sarikamis Military Hospital, Kars, Turkey; 2Faculty of Medicine, Department of Ophthalmology, Gulhane Military Medical Academy, Ankara, Turkey; 3Department of Ophthalmology, Canakkale Military Hos...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gokce G, Sobaci G, Durukan AH, Erdurman FC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/729f8639d16940aebb43d80eb510b8f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:729f8639d16940aebb43d80eb510b8f4
record_format	dspace
spelling	oai:doaj.org-article:729f8639d16940aebb43d80eb510b8f42021-12-02T02:01:39ZThe comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion1177-5483https://doaj.org/article/729f8639d16940aebb43d80eb510b8f42014-02-01T00:00:00Zhttp://www.dovepress.com/the-comparison-of-intravitreal-triamcinolone-and-bevacizumab-in-patien-a15729https://doaj.org/toc/1177-5483 Gokcen Gokce,1 Gungor Sobaci,2 Ali Hakan Durukan,2 Fazil Cuneyt Erdurman31Department of Ophthalmology, Sarikamis Military Hospital, Kars, Turkey; 2Faculty of Medicine, Department of Ophthalmology, Gulhane Military Medical Academy, Ankara, Turkey; 3Department of Ophthalmology, Canakkale Military Hospital, Canakkale, TurkeyPurpose: This study was conducted to compare the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) and intravitreal bevacizumab (IVB) in the treatment of macular edema related to branch retinal vein occlusion (BRVO), using the new optical coherence tomography parameters.Material and methods: The medical records of 62 patients (IVTA n=26; IVB n=36) with macular edema secondary to BRVO and at least 12 months follow-up between 2007 and 2011 were evaluated by within-group and inter-group comparisons.Results: Both groups were similar in terms of demographic characteristics (P>0.05). Best corrected visual acuity (BCVA) improvement and central subfoveal thickness (CST) reduction were significantly higher in the IVTA group at only the third month (P<0.05). In nonischemic BRVO, while BCVA improvement was significantly higher in the IVTA group at the third and sixth months (P<0.05), no significant difference was found in CST reduction at all visits (P>0.05). In ischemic BRVO, no significant difference was found in BCVA improvement at all visits, but CST reduction was significantly higher in the IVTA group at the first and third months. Logarithmic optical coherence tomography change (LogOCTc) and relative change in retinal thickness (RCRT) showed the same levels of significance in the comparisons. Relative change in retinal thickening (RCRTing) was more valuable compared to the other parameters in the subgroup analyses.Conclusion: There was no difference between groups at the 12th month. IVTA was more efficient than IVB in regard to BCVA improvement in nonischemic BRVO in the early follow-up. IVTA made significant retinal thinning compared to IVB in ischemic BRVO in the early period. RCRTing and LogOCTc are important parameters used to monitor the response to treatment in BRVO. Because of the similar levels of significance, RCRT and LogOCTc can be used interchangeably.Keywords: branch retinal vein occlusion, bevacizumab, macular edema, triamcinoloneGokce GSobaci GDurukan AHErdurman FCDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2014, Iss default, Pp 355-362 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Gokce G Sobaci G Durukan AH Erdurman FC The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
description	Gokcen Gokce,1 Gungor Sobaci,2 Ali Hakan Durukan,2 Fazil Cuneyt Erdurman31Department of Ophthalmology, Sarikamis Military Hospital, Kars, Turkey; 2Faculty of Medicine, Department of Ophthalmology, Gulhane Military Medical Academy, Ankara, Turkey; 3Department of Ophthalmology, Canakkale Military Hospital, Canakkale, TurkeyPurpose: This study was conducted to compare the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) and intravitreal bevacizumab (IVB) in the treatment of macular edema related to branch retinal vein occlusion (BRVO), using the new optical coherence tomography parameters.Material and methods: The medical records of 62 patients (IVTA n=26; IVB n=36) with macular edema secondary to BRVO and at least 12 months follow-up between 2007 and 2011 were evaluated by within-group and inter-group comparisons.Results: Both groups were similar in terms of demographic characteristics (P>0.05). Best corrected visual acuity (BCVA) improvement and central subfoveal thickness (CST) reduction were significantly higher in the IVTA group at only the third month (P<0.05). In nonischemic BRVO, while BCVA improvement was significantly higher in the IVTA group at the third and sixth months (P<0.05), no significant difference was found in CST reduction at all visits (P>0.05). In ischemic BRVO, no significant difference was found in BCVA improvement at all visits, but CST reduction was significantly higher in the IVTA group at the first and third months. Logarithmic optical coherence tomography change (LogOCTc) and relative change in retinal thickness (RCRT) showed the same levels of significance in the comparisons. Relative change in retinal thickening (RCRTing) was more valuable compared to the other parameters in the subgroup analyses.Conclusion: There was no difference between groups at the 12th month. IVTA was more efficient than IVB in regard to BCVA improvement in nonischemic BRVO in the early follow-up. IVTA made significant retinal thinning compared to IVB in ischemic BRVO in the early period. RCRTing and LogOCTc are important parameters used to monitor the response to treatment in BRVO. Because of the similar levels of significance, RCRT and LogOCTc can be used interchangeably.Keywords: branch retinal vein occlusion, bevacizumab, macular edema, triamcinolone
format	article
author	Gokce G Sobaci G Durukan AH Erdurman FC
author_facet	Gokce G Sobaci G Durukan AH Erdurman FC
author_sort	Gokce G
title	The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
title_short	The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
title_full	The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
title_fullStr	The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
title_full_unstemmed	The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
title_sort	comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/729f8639d16940aebb43d80eb510b8f4
work_keys_str_mv	AT gokceg thecomparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT sobacig thecomparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT durukanah thecomparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT erdurmanfc thecomparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT gokceg comparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT sobacig comparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT durukanah comparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion AT erdurmanfc comparisonofintravitrealtriamcinoloneandbevacizumabinpatientswithmacularedemasecondarytobranchretinalveinocclusion
_version_	1718402783927861248

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion

Ejemplares similares